These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2057304)

  • 41. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 42. Anticoagulant and thrombolytic therapies in women.
    Schwartz JB
    J Gend Specif Med; 2002; 5(1):14-8. PubMed ID: 11859682
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antithrombotic therapy and its laboratory monitoring (lecture)].
    Vavilova TV
    Klin Lab Diagn; 2004 Dec; (12):21-32. PubMed ID: 15739768
    [No Abstract]   [Full Text] [Related]  

  • 44. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Weitz JI; Hirsh J; Samama MM
    Chest; 2004 Sep; 126(3 Suppl):265S-286S. PubMed ID: 15383475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. State of the art--a journey through the world of antithrombotic therapy.
    Turpie AG
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():3-11. PubMed ID: 12232817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The current achievements and problems of thrombolytic therapy].
    Bokarev IN
    Ter Arkh; 1992; 64(10):101-5. PubMed ID: 1485236
    [No Abstract]   [Full Text] [Related]  

  • 49. [Your patient needs an antithrombotic drug, 4: Recurrence prevention after thrombosis: how long and with what?].
    Stiefehlhagen P
    MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):28. PubMed ID: 24260916
    [No Abstract]   [Full Text] [Related]  

  • 50. Anticoagulation recidivans.
    N Engl J Med; 1968 May; 278(22):1231-2. PubMed ID: 5647745
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrinolytic system in atherosclerosis.
    Balkuv-Ulutin S
    Semin Thromb Hemost; 1986 Apr; 12(2):91-101. PubMed ID: 3738530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New antithrombotic agents in the management of venous thromboembolism.
    Piovella F; Barone M; Serafini S; Natalizi A; Librè L; Beltrametti C; Piovella C
    Haematologica; 2001 Nov; 86(11 Suppl 2):63-4. PubMed ID: 11926782
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombolysis in extremital arteries--indications and methods.
    Wellander E; Risberg B
    Ann Chir Gynaecol; 1995; 84(4):341-8. PubMed ID: 8687077
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hopes, joys and disappointments of surgeons in connection with the development of the blood coagulation problem].
    Filatov AN
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):3-10. PubMed ID: 5397112
    [No Abstract]   [Full Text] [Related]  

  • 55. Fibrinogen and catheter-directed thrombolysis.
    Ross RL; Beck AW
    Semin Vasc Surg; 2014 Dec; 27(3-4):182-95. PubMed ID: 26073829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Valvular prosthesis: indications and updated protocols for thrombosis prophylaxis].
    Dalla Volta S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):331-40. PubMed ID: 7634293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention and treatment of thromboembolic complications in patients with facial furunculosis and carbuncles].
    Zakharova GN; Bulkin VA; Lepilin AV
    Vestn Khir Im I I Grek; 1989 Jul; 143(7):100-2. PubMed ID: 2595910
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
    Tay KH; Khoo CW; Lip GY
    J Heart Valve Dis; 2009 May; 18(3):276-7. PubMed ID: 19557982
    [No Abstract]   [Full Text] [Related]  

  • 60. Reflections of thrombosis research in Oklahoma City--1975 to the present.
    Green R
    J Okla State Med Assoc; 1999 Mar; 92(3):131-9. PubMed ID: 10087676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.